cyclosporine has been researched along with Bone Marrow Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aamdal, S; Andersson, Y; Brunsvig, P; Dueland, S; Engebraaten, O; Fodstad, Ø; Juell, S | 1 |
| Ansari-Lari, A; Brodsky, RA; Veidt, RG | 1 |
1 trial(s) available for cyclosporine and Bone Marrow Neoplasms
| Article | Year |
|---|---|
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin.
Topics: Adult; Aged; Alanine Transaminase; Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Bone Marrow Neoplasms; Carcinoma; Cell Adhesion Molecules; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Interactions; Epithelial Cell Adhesion Molecule; Female; Half-Life; Humans; Immunoconjugates; Infusions, Intravenous; Lethal Dose 50; Macaca fascicularis; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Micrometastasis; Neoplasms; Treatment Outcome | 2015 |
1 other study(ies) available for cyclosporine and Bone Marrow Neoplasms
| Article | Year |
|---|---|
Severe aplastic anemia associated with paroxysmal nocturnal hemoglobinuria and lymphoplasmacytic lymphoma.
Topics: Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Neoplasms; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fatal Outcome; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Time Factors; Waldenstrom Macroglobulinemia | 2005 |